Ponoi II Management, LLC
- SEC CIK
- 0001746488
- Latest filing
- Nov 14, 2022
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 4
- 0 vs. Q2 2022
- Portfolio value
- $38.3M
- +$1.46M (+4.0%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $17.0M | 44.4% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $13.5M | 35.3% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 327,123 | $4.26M | 11.1% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 145,401 | $3.50M | 9.1% | 00.0% | Unchanged | History |